Wrong again. State investments are behind most new drugs. US National Institutes of Health spend $40 billion/year on drug innovation. Real question is how to make sure that investment is governed for the public interest and not private profit. More info https://t.co/WUhiDkrNj4 https://t.co/j7Yyfjw5g0— Mariana Mazzucato (@MazzucatoM) October 7, 2020